# Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat

> **NCT06569589** · — · RECRUITING · sponsor: **Jens Titze** · enrollment: 80 (estimated)

## Conditions studied

- Hypertension
- Primary Aldosteronism
- Hypokalemia

## Interventions

- **DIAGNOSTIC_TEST:** 23NaMRI Scan
- **DIETARY_SUPPLEMENT:** Potassium Chloride (KCl)

## Key facts

- **NCT ID:** NCT06569589
- **Lead sponsor:** Jens Titze
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-27
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-06-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06569589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06569589, "Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06569589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*